What Do We Actually Know About the ADHD Brain?
It’s understandable to want something concrete when you’re trying to understand ADHD.
Perhaps a brain scan that shows where ADHD appears, a particular region that helps explain why attention can be so inconsistent, or something about dopamine that makes sense of why starting one task can feel unexpectedly difficult while another absorbs you completely.
These ideas aren’t coming from nowhere. Dopamine really is relevant to ADHD. Researchers really have found differences in brain structure, activity and connectivity. The prefrontal cortex really does play an important role in many of the processes associated with ADHD.
What’s interesting is what happens when we look a little more closely.
Rather than pointing towards one distinct feature that defines an “ADHD brain”, decades of research are revealing something more complex: differences spread across interacting biological systems, considerable variation between people, and multiple possible pathways through which ADHD develops and is experienced.
The picture is less tidy than a single brain diagram might suggest.
But it’s also much richer.
ADHD has substantial biological foundations
ADHD is a neurodevelopmental condition, and researchers have studied its biological foundations from many different directions, including family and genetic research, cognitive studies, brain imaging and research into neurochemical signalling.
Genetics provides one particularly strong part of this picture.
ADHD tends to run in families, and large genetic studies indicate substantial heritability. Rather than finding one particular “ADHD gene”, researchers have found something more complex. ADHD is understood as polygenic, meaning that many genetic variants each appear to contribute a small amount to the likelihood of developing the condition.
Those genetic influences operate within development. They don’t function as a simple set of instructions determining exactly how someone will think, behave or experience ADHD.
This gives us an important starting point.
ADHD has substantial biological foundations, while the way those foundations develop and eventually appear in a person’s life can vary considerably.
Researchers have found differences in the brain
Brain-imaging research adds another part to the picture.
When researchers compare large groups of people with and without ADHD, they have identified average differences in aspects of brain structure, development, activation and connectivity. Some findings involve regions and systems associated with processes such as attention, inhibition, movement and reward.
The important word here is average.
Imagine researchers measure a particular feature of the brain in hundreds or thousands of people with ADHD and compare the results with people who don’t have ADHD. They may find a reliable difference between the averages of the two groups.
That doesn’t necessarily mean the two groups separate neatly.
There can still be considerable overlap between individual people. Some people with ADHD may have measurements very similar to people without ADHD, and vice versa.
This helps explain something that can otherwise seem puzzling about ADHD neuroscience.
Researchers can find meaningful biological patterns associated with ADHD without those patterns appearing identically in every individual person who has it.
The prefrontal cortex is part of a much bigger system
If you’ve read about the ADHD brain before, there’s a good chance you’ve encountered the prefrontal cortex.
And for good reason.
Prefrontal regions contribute to processes including planning, inhibition, working memory and goal-directed behaviour, all of which are relevant to our understanding of ADHD.
Earlier and simpler explanations of the brain often made it tempting to think of regions in fairly separate terms: one area for memory, another for attention, another acting as the brain’s “control centre”.
Contemporary neuroscience gives us a more interconnected picture.
Complex behaviours don’t usually arise from one brain region working alone. Attention, movement, memory, motivation and behavioural regulation depend upon communication between many regions and systems, with patterns of activity changing according to what we’re doing.
That’s why much contemporary ADHD research looks not only at individual brain regions, but at networks and the ways different parts of the brain communicate with one another.
The prefrontal cortex still matters.
It simply belongs within a much larger story.
Brain networks give us another way to understand ADHD
A brain network isn’t a separate piece of anatomy. It refers to a collection of regions whose activity tends to work together during particular kinds of tasks or mental states.
ADHD research has examined several networks involved in attention and cognitive control.
Frontal and parietal systems contribute to directing and sustaining attention towards goals. Other systems are involved in detecting what is important or salient and helping attention shift towards it. Researchers have also studied the default mode network, which is associated with internally directed thought and interacts with networks involved in externally focused tasks.
Differences in the activation and coordination of these systems have been reported in ADHD research.
These findings can help researchers build a richer understanding of ADHD, although there’s still a large distance between identifying a pattern across many brains and explaining an individual experience.
If your attention wandered during a meeting yesterday, neuroscience can’t tell us precisely what happened in your brain at that moment. If beginning a task felt almost impossible this morning, we can’t look at the research and assign that experience to one particular network.
Neuroscience gives us one level of understanding: patterns across populations, development and interacting biological systems.
Our individual lives operate at another.
Both can be useful without expecting one to completely explain the other.
And then there’s dopamine
Dopamine may be the most familiar biological idea associated with ADHD.
You may have heard ADHD described as involving “low dopamine”, a dopamine deficiency, or a brain that is constantly seeking dopamine.
There’s an understandable reason dopamine has become such a prominent part of the conversation.
Dopamine is an important neurotransmitter involved in several processes relevant to ADHD, including reward, motivation, learning and aspects of cognitive and motor regulation. ADHD medications also interact with neurotransmitter systems involving dopamine and norepinephrine.
So dopamine absolutely belongs in our understanding of ADHD.
What research gives us, though, is a more detailed picture than a simple measure of how much dopamine someone has.
Neurotransmitter systems involve production, release, transport, receptors, timing and communication across different pathways. Researchers study different parts of those systems using different methods, and findings can vary depending upon the population being studied.
This means that when researchers talk about dopamine involvement or dopamine signalling, they’re describing something much more dynamic than a tank that happens to be running low.
The familiar “low dopamine” explanation can be a useful doorway into the subject.
It just isn’t the whole room.
Norepinephrine is part of the picture too
Dopamine receives much of the public attention, but norepinephrine, also called noradrenaline, is another neurotransmitter involved in systems relevant to attention, alertness and cognitive regulation.
Dopamine and norepinephrine systems interact, both feature in current biological models of ADHD, and both are affected by some ADHD medications.
Knowing this can add another layer to the way we understand brain chemistry and ADHD.
It can also help us resist the temptation to translate every individual experience into a moment-by-moment chemical explanation.
Feeling unusually unmotivated one afternoon doesn’t tell us what someone’s dopamine system is doing at that precise moment. Nor does an afternoon of unusually good concentration mean their brain chemistry has suddenly shifted into a “normal” state.
Our subjective experience and the neurobiology underneath it are connected.
The relationship between them is simply far more complex than we can currently observe from moment to moment.
What medication can tell us
Medication adds another interesting piece to the biological picture.
Stimulant medications affect dopamine and norepinephrine signalling, and they can reduce ADHD symptoms for many people. Understandably, this has sometimes contributed to the idea that medication is replacing something the ADHD brain lacks.
The relationship isn’t quite that direct.
A medication can influence a biological system and improve symptoms without telling us that a deficiency in that system was the original cause of the condition.
Pain relief offers a simple comparison. A medication can reduce pain without the pain having been caused by a shortage of that medication in the body.
ADHD medication gives researchers valuable information about biological systems that can influence attention, inhibition, motivation and other ADHD-related processes.
What it doesn’t give us is a simple chemical reading of an individual person’s ADHD.
Biology doesn’t mean fixed
There’s another question that often appears once we begin thinking about ADHD biologically.
If ADHD develops in the brain, does that mean the way someone functions is essentially fixed?
Our understanding of development suggests something much more dynamic.
Brains develop and function within environments. Sleep, stress, physical health, learning, relationships, treatment, support and everyday demands can all affect how easily someone functions at a particular time.
Someone may find attention easier to regulate when adequately rested. External structure may reduce the demands placed on working memory or time management. Medication may change how accessible attention and behavioural regulation feel. A supportive environment may make a particular ADHD difficulty far less disruptive.
None of these things makes ADHD less neurodevelopmental.
They remind us that biology is responsive to context.
A biological foundation and a changing everyday experience can exist at the same time.
There may be more than one pathway to ADHD
Spend time with a group of people with ADHD and the variation quickly becomes apparent.
People can meet diagnostic criteria through different combinations of symptoms. Some experience prominent inattentive difficulties, others have stronger hyperactive and impulsive symptoms, and many meet criteria across both domains.
People also differ in their cognitive profiles, genetics, development, co-occurring conditions and environments.
Researchers often describe this as heterogeneity.
Put simply, ADHD is varied rather than biologically uniform.
Two people can share a valid ADHD diagnosis without having identical symptoms, cognitive profiles or findings across every biological measure researchers study. There may also be multiple developmental pathways that eventually contribute to the pattern we recognise clinically as ADHD.
In some ways, this biological variation mirrors what we already see in everyday life.
There isn’t one way to experience ADHD.
Perhaps we shouldn’t expect there to be one perfectly uniform biological story underneath it either.
So why can’t we diagnose ADHD with a brain scan?
Given how much neuroscience has discovered, this is a reasonable question.
Brain imaging is extremely useful for studying ADHD. It allows researchers to investigate average differences between groups, examine aspects of brain development and connectivity, and test theories about the biological systems involved.
Clinical diagnosis asks a different question.
Rather than asking whether a pattern exists across a large population, it needs to determine whether one particular person has ADHD, accurately and reliably enough to guide clinical decisions.
At present, brain imaging can’t do that.
The differences identified in research aren’t sufficiently specific or consistent at an individual level to replace clinical assessment. There’s also overlap between ADHD and other conditions in some of the biological and cognitive systems being studied.
For now, then, a brain scan isn’t part of routine ADHD diagnosis.
Diagnosis continues to rely on the recognised clinical pattern: developmental history, symptoms across settings, their impact on functioning, and careful consideration of other possible explanations.
Brain imaging and clinical assessment are doing different jobs.
One helps researchers investigate the biology associated with ADHD across populations.
The other helps clinicians understand the person sitting in front of them.
Complexity is part of scientific progress
It can feel slightly surprising that after decades of research, enormous genetic datasets and increasingly sophisticated brain-imaging technology, the answer to “what does an ADHD brain look like?” remains so nuanced.
But that nuance tells us something about how the science itself has developed.
Larger studies allow researchers to see whether findings from smaller samples hold up. Genetic research can examine enormous numbers of variants rather than searching for one ADHD gene. Network approaches allow researchers to study communication across systems rather than assuming a single region controls a complex behaviour.
Researchers are also increasingly able to examine variation between people rather than treating everyone with ADHD as biologically identical.
As the tools become more sophisticated, the questions become more sophisticated too.
Sometimes better science produces fewer sweeping statements.
That isn’t a weakness.
It’s what happens when our understanding becomes more precise.
Why simple explanations can still be useful
There’s a reason ideas such as “low dopamine” or an “underactive control centre” have become so familiar.
They give us something tangible.
For someone who has spent years being told they need more discipline, motivation or effort, discovering that there are biological processes associated with ADHD can also bring enormous relief.
Suddenly there’s another way to understand an experience that may previously have been interpreted in moral terms.
That shift matters.
The next step doesn’t have to be throwing those simpler explanations away. It can simply be adding more detail to them.
Dopamine is involved, alongside other neurotransmitter systems.
Prefrontal regions matter, as part of larger interacting networks.
Brain differences have been identified, while also varying considerably between individuals.
ADHD has substantial biological and developmental foundations without requiring one particular region, chemical or brain pattern to explain every person who has it.
The deeper we look, the more layered the picture becomes.
A scan couldn’t tell you what ADHD means in your life anyway
There’s also something neuroscience was never designed to tell us.
A scan can’t show the years you spent creating systems around something that seemed easier for everyone else.
It can’t tell us whether difficulty regulating attention matters most while you’re working, getting everyone out of the house in the morning, or trying to stay present in a conversation.
It can’t show which environments allow you to function well.
And it can’t tell us what you came to believe about yourself because of experiences you didn’t yet understand.
Those questions belong at a different level of understanding.
Biology helps us investigate the foundations and mechanisms associated with ADHD. Lived experience helps us understand what those differences have meant within a particular person’s life.
We don’t need to choose between the two.
They’re different parts of the same story.
If you’re exploring whether ADHD might explain your experience
You don’t need biological proof before it’s reasonable to wonder about ADHD.
At the same time, recognising yourself in a description of dopamine, brain networks or executive functioning can only tell you so much. Difficulties involving attention, motivation, memory, restlessness or impulse control can occur for many reasons.
That’s why ADHD assessment looks at the broader pattern across a person’s life: developmental history, experiences across different settings, the impact on functioning, and whether other explanations might better account for what is happening.
Neuroscience adds to our understanding of the biological foundations beneath that clinical picture.
It isn’t expected to tell the whole story.
The picture we have is complex, but substantial
So what do we actually know about the ADHD brain?
We know that ADHD has substantial biological and genetic foundations.
Research has identified average differences associated with ADHD across aspects of brain development, structure, activation and connectivity. Distributed brain networks have helped researchers understand complex cognitive processes in more sophisticated ways, while neurotransmitter systems involving dopamine and norepinephrine remain important parts of current biological models.
We also know that there’s considerable variation within ADHD.
There may be multiple developmental and biological pathways involved, and we don’t currently have one brain feature, chemical measurement or scan that identifies ADHD reliably in an individual person.
Perhaps that leaves us with a more interesting understanding of what “biological” actually means.
It doesn’t have to mean one thing has gone wrong in one place.
It can mean genes, development, brain systems, neurochemistry and environment interacting across a lifetime, producing patterns that researchers can increasingly understand while still leaving room for considerable individual variation.
There may never be one picture we can point to and say, There. That’s the ADHD brain.
What science is giving us instead is a gradually clearer understanding of the many processes that can contribute to ADHD.
And perhaps that’s a more useful picture after all.
A moment to wonder
When you’ve encountered explanations of the ADHD brain, which ones have stayed with you?
Perhaps it was dopamine. A particular part of the brain. Brain scans. Or simply the idea that an ADHD brain is “wired differently”.
You don’t need to go back through everything you’ve heard and sort it into right and wrong.
You might simply hold those explanations a little more loosely now, knowing that many contain a thread of genuine science while the fuller picture is usually more layered.
And as research continues, that picture will keep developing.
Keep exploring
There’s more to explore across Through the Disconnect, from understanding ADHD and life after diagnosis to masking and making sense of your experience.
References
American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.; DSM-5-TR). American Psychiatric Association Publishing.
Australian ADHD Professionals Association. (2022). Australian evidence-based clinical practice guideline for attention deficit hyperactivity disorder (ADHD).
Chen, C., et al. (2025). A multimodal neuroimaging meta-analysis of functional and structural brain abnormalities in attention-deficit/hyperactivity disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 111199.
Demontis, D., Walters, G. B., Athanasiadis, G., et al. (2023). Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics, 55, 198–208.
Faraone, S. V., Bellgrove, M. A., Brikell, I., et al. (2024). Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers, 10, 11.
Faraone, S. V., Banaschewski, T., Coghill, D., et al. (2021). The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neuroscience & Biobehavioral Reviews, 128, 789–818.
Hoogman, M., Bralten, J., Hibar, D. P., et al. (2017). Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: A cross-sectional mega-analysis. The Lancet Psychiatry, 4(4), 310–319.
Hoogman, M., Muetzel, R., Guimaraes, J. P., et al. (2019). Brain imaging of the cortex in ADHD: A coordinated analysis of large-scale clinical and population-based samples. American Journal of Psychiatry, 176(7), 531–542.
Koirala, S., Grimsrud, G., Mooney, M. A., et al. (2024). Neurobiology of attention-deficit hyperactivity disorder: Historical challenges and emerging frontiers. Nature Reviews Neuroscience, 25, 759–775.
Parlatini, V., Bellato, A., Gabellone, A., et al. (2024). A state-of-the-art overview of candidate diagnostic biomarkers for attention-deficit/hyperactivity disorder (ADHD). Expert Review of Molecular Diagnostics, 24(4), 259–271.
Tripp, G., & Wickens, J. R. (2009). Neurobiology of ADHD. Neuropharmacology, 57(7–8), 579–589.
Volkow, N. D., Wang, G.-J., Kollins, S. H., et al. (2009). Evaluating dopamine reward pathway in ADHD: Clinical implications. JAMA, 302(10), 1084–1091.
